We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Scientists, including one of Indian-origin, have identified parts of human proteins which thehuman proteins could be using to hijack host cell processes, an advance that may lead to the development of new drugs for treating COVID-19.
Scientists at the European Molecular Biology Laboratory (EMBL) have developed a new microfluidic device to facilitate fast and inexpensive testing of cancer drugs on tumour cells.
Sartorius has announced a partnership with EMBL, the European Molecular Biology Laboratory. EMBL is one of the Europe’s leading research institutions with global reach.